.png){kind=small}
Max Funding
Varies
.png){kind=small}
Application Due Date
Rolling
.png){kind=small}
Funder Details:
Funder Type:
Corporate
Funding Frequency:
Rolling Basis
Use of Funds:
Programs/Projects
Funding Duration:
One-Year Grant
Application Type
Full Application
Eligibility:
✅ 501(c)(3) Organizations
Program Areas:
Health, Education, LGBTQIA+, Research, International, Social Services, Homelessness, Arts & Culture, Food Security, Women's Shelter, Homelessness Shelter, Family Shelter, Healthcare, STEM Education, Higher Education Institutions
Locations:
Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming, Puerto Rico, Washington DC
About The Grant
Gilead has worked with local partners to provide our medicines throughout Latin America and the Caribbean. Gilead therapies continue to address unmet medical needs in the region, bringing innovative and life-saving treatments to communities in Argentina, Belize, Brazil, Haiti, Jamaica and elsewhere.
The efforts of our corporate contributions team build upon our overall mission, as we identify and support organizations that seek to:
Improve access to healthcare
Reduce disparities for disadvantaged groups
Advance education among patients and healthcare professionals
Support local communities
In Latin America and the Caribbean, funding priority is given to projects within Gilead’s therapeutic areas of HIV and liver diseases.
HIV-AIDS
Gilead supports organizations working to help individuals learn their status and get the care they need. We also fund groups looking to meet the unique needs of the region, including:
Increasing awareness and understanding of HIV incidence and treatment methods
Facilitating medicine provision and local provider expertise
Supporting linkage to care programs
Identifying and fostering prevention programs for at-risk individuals; for example, via pre-exposure prophylaxis (PrEP)
Liver Disease
Gilead is working to improve the overall continuum of care for liver diseases by funding organizations that:
Ensure providers have the training and expertise they need to deliver proper care
Improve infrastructure and screening ability of regions where care is dependent on viral load
Reduce undiagnosed totals
Increase awareness of risk factors
Other
Though priority is given to projects related to HIV- and liver disease-related projects, Gilead will consider grant proposals outside of these therapeutic areas, provided they conform to our eligibility restrictions. These proposals may include (but are not limited to):
Access and education surrounding antifungal treatments
Social services (homeless shelters, food banks, etc.)
Community vibrancy projects (STEM education, arts support, community beautification, etc.)
We accept grant applications year-round. Keep in mind that you must submit the application at least six weeks before your activity begins, and that it typically takes approximately six to 12 weeks for review.
Requirements
Tax exempt registration is required to be considered for funding, and if you are a nonprofit organization, proof of status (e.g., a 501(c)(3) IRS letter in the U.S. or a tax certification letter (W8-BEN) if your organization is based outside the U.S.) is also required.
Grantor Information:
Restrictions:
Restricted